|
Red Cells
Citations 231-240 of 1173 total displayed.
|
Past content
(since Jan 1997):
|
Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA)
- John J. Strouse, Christiane S. Cox, Elias R. Melhem, Hanzhang Lu, Michael A. Kraut, Alexander Razumovsky, Kaleb Yohay, Peter C. van Zijl, and James F. Casella
Blood 2006; 108: 379-381.
[Abstract]
[Full text]
[PDF]
Coordination of erythropoiesis by the transcription factor c-Myb
- Alexandros Vegiopoulos, Paloma García, Nikla Emambokus, and Jon Frampton
Blood 2006; 107: 4703-4710.
[Abstract]
[Full text]
[PDF]
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise
- Monique Beullens, Joris R. Delanghe, and Mathieu Bollen
Blood 2006; 107: 4711-4713.
[Abstract]
[Full text]
[PDF]
Molecular pathogenesis of Fanconi anemia: recent progress
- Toshiyasu Taniguchi and Alan D. D'Andrea
Blood 2006; 107: 4223-4233.
[Abstract]
[Full text]
[PDF]
Impact of anemia on hospitalization and mortality in older adults
- Bruce F. Culleton, Braden J. Manns, Jianguo Zhang, Marcello Tonelli, Scott Klarenbach, and Brenda R. Hemmelgarn
Blood 2006; 107: 3841-3846.
[Abstract]
[Full text]
[PDF]
T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia
- Elena E. Solomou, Keyvan Keyvanfar, and Neal S. Young
Blood 2006; 107: 3983-3991.
[Abstract]
[Full text]
[PDF]
Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease
- Igor Theurl, Verena Mattle, Markus Seifert, Mariagabriella Mariani, Christian Marth, and Günter Weiss
Blood 2006; 107: 4142-4148.
[Abstract]
[Full text]
[PDF]
Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis
- Matthias Schranzhofer, Manfred Schifrer, Javier Antonio Cabrera, Stephan Kopp, Peter Chiba, Hartmut Beug, and Ernst W. Müllner
Blood 2006; 107: 4159-4167.
[Abstract]
[Full text]
[PDF]
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with  -thalassemia
- Maria Domenica Cappellini, Alan Cohen, Antonio Piga, Mohamed Bejaoui, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Antonis Kattamis, Yurdanur Kilinc, John Porter, Marcello Capra, Renzo Galanello, Slaheddine Fattoum, Guillermo Drelichman, Carmelo Magnano, Monica Verissimo, Miranda Athanassiou-Metaxa, Patricia Giardina, Alexandra Kourakli-Symeonidis, Gritta Janka-Schaub, Thomas Coates, Christiane Vermylen, Nancy Olivieri, Isabelle Thuret, Herbert Opitz, Catherine Ressayre-Djaffer, Peter Marks, and Daniele Alberti
Blood 2006; 107: 3455-3462.
[Abstract]
[Full text]
[PDF]
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
- Caterina Borgna-Pignatti, Maria Domenica Cappellini, Piero De Stefano, Giovanni Carlo Del Vecchio, Gian Luca Forni, Maria Rita Gamberini, Roberta Ghilardi, Antonio Piga, Maria Antonietta Romeo, Huaqing Zhao, and Avital Cnaan
Blood 2006; 107: 3733-3737.
[Abstract]
[Full text]
[PDF]
|
|
